Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $134.41 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $40.87 | 3 | $0 (2022) |
| Novo Nordisk Inc | $39.35 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $23.85 | 1 | $0 (2023) |
| Lilly USA, LLC | $18.43 | 1 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $11.91 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.85 | 1 | GlaxoSmithKline, LLC. ($23.85) |
| 2022 | $51.74 | 3 | Novo Nordisk Inc ($39.35) |
| 2021 | $58.82 | 4 | Merck Sharp & Dohme Corporation ($28.48) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), ROTARIX | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: VACCINES | ||||||
| 09/30/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Obesity | ||||||
| 09/03/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), JANUVIA, VERQUVO | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Diabetes | ||||||
| 12/11/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Neuroscience | ||||||
| 12/01/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: PRIMARY CARE | ||||||
| 10/06/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: NEUROSCIENCE | ||||||
About Lily Jhang
Lily Jhang is a Primary Care healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1184026759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lily Jhang has received a total of $134.41 in payments from pharmaceutical and medical device companies, with $23.85 received in 2023. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($134.41).
Practice Information
- Specialty Primary Care
- Location Sacramento, CA
- Active Since 09/25/2014
- Last Updated 11/07/2025
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1184026759
Products in Payments
- BELSOMRA (Drug) $40.87
- SHINGRIX (Biological) $23.85
- Rybelsus (Drug) $22.03
- EMGALITY (Drug) $18.43
- Saxenda (Drug) $17.32
- NURTEC ODT (Drug) $11.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Sacramento
Veronica Ramirez, N.p, N.P
Primary Care — Payments: $50,395
Sapandip Walia, Fnp, FNP
Primary Care — Payments: $2,479
Ly Kong Pheng Jalao
Primary Care — Payments: $944.69
Maria Stoner, N.p, N.P
Primary Care — Payments: $938.35
Araceli Gutierrez
Primary Care — Payments: $799.74
Christi Delemos, Np, NP
Primary Care — Payments: $762.29